These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2903686)

  • 21. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 22. Tardive dystonia in Chinese.
    Chiu HF; Leung JY; Lee S
    Singapore Med J; 1989 Oct; 30(5):441-3. PubMed ID: 2575797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dystonia: four case histories.
    Yadalam KG; Korn ML; Simpson GM
    J Clin Psychiatry; 1990 Jan; 51(1):17-20. PubMed ID: 1967246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risks of long-term neuroleptic treatment of schizophrenia: especially depression and akinesia.
    Rifkin A
    Acta Psychiatr Scand Suppl; 1981; 291():129-36. PubMed ID: 6113730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extrapyramidal side effects with lithium treatment.
    Kane J; Rifkin A; Quitkin F; Klein DF
    Am J Psychiatry; 1978 Jul; 135(7):851-3. PubMed ID: 665801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon.
    Bermanzohn PC; Siris SG
    J Clin Psychiatry; 1994 Nov; 55(11):488-91. PubMed ID: 7989282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
    Cancro R; Davis JM; Klawans H; Tancredi L
    J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot neuroleptic therapy: an underutilized treatment option.
    Glazer WM; Kane JM
    J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J
    J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive and chronically recurrent oculogyric crises.
    Sachdev P
    Mov Disord; 1993; 8(1):93-7. PubMed ID: 8093550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
    Tenback DE; van Harten PN; Slooff CJ; van Os J
    Am J Psychiatry; 2006 Aug; 163(8):1438-40. PubMed ID: 16877660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic treatment of schizophrenia.
    Levinson DF
    Clin Ther; 1991; 13(3):326-52. PubMed ID: 1683269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute dystonia with intramuscular olanzapine in adolescent mania: a report.
    Goyal N; Thakur A; Sinha VK
    Aust N Z J Psychiatry; 2005; 39(11-12):1046-7. PubMed ID: 16343308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.